CRDF

Cardiff Oncology Inc. Common Stock (CRDF)

Stock · NASDAQ · Health Care

$0.94as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$1.55
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Cardiff Oncology Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • CRDF
    Cardiff Oncology Inc. Common Stock
    $0.94
    ▼ 5.05%
    Market cap $74.71MP/E
  • ATRA
    Atara Biotherapeutics Inc. Common Stock
    $9.16
    ▼ 0.97%
    Market cap $74.33MP/E
    $3.92$19.15
  • ELOX
    Eloxx Pharmaceuticals Inc. Common Stock
    $15.07
    ▼ 12.69%
    Market cap $71.48MP/E 5.33
    $0$23.4
  • CGTX
    Cognition Therapeutics Inc. Common Stock
    $1.03
    ▼ 3.30%
    Market cap $79.79MP/E
    $0.5501$3.1
  • IMA
    ImageneBio Inc. Common Stock
    $5.34
    ▲ 0.19%
    Market cap $63.50MP/E
    $3.94$13.98
  • GNTA
    Genenta Science S.p.A. American Depositary Shares
    $1
    ▼ 1.96%
    Market cap $63.16MP/E
    $0.55$10
  • SCLX
    Scilex Holding Company Common Stock
    $5.42
    ▼ 2.69%
    Market cap $58.93MP/E
    $4.2$34.27

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
24.21M
Total value held
$38.79M
Institutional holders
111
Top holders this quarter
  • Unknown3.98M
  • Unknown2.86M
  • Unknown2.65M
  • Unknown2.41M
  • Unknown1.76M
  • Unknown1.60M
  • Unknown1.21M
  • Unknown1.19M
  • Unknown922.4K
  • Unknown595.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.